FAQ

RS-130830

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2015
01220002015

Related topics

Related topics

1 relation

Broader (1)

Hydroxamic Acids

Related mentions per year

Related mentions per year

1946-2018
19401960198020002020
RS-130830
Hydroxamic Acids

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The matrix metalloproteinase inhibitor RS-130830 attenuates brain injury in experimental pneumococcal meningitis
Pneumococcal meningitis (PM) is characterized by high mortality and morbidity including long-term neurofunctional deficits… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
Is this relevant?
2006
2006
Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability.
OBJECTIVE Matrix metalloproteinases (MMPs) form a large family of enzymes that collectively can degrade all components of the… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts.
The balance between matrix metalloproteinases (MMPs) and their natural inhibitors, the tissue inhibitors of metalloproteinases… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • table 1
Is this relevant?
2005
2005
Validation of a diffusion chamber as in vitro system for the analysis of compound diffusibility through cartilage tissue.
The validation of a diffusion chamber comprising a donor and a receptor side separated by a cartilage membrane was undertaken… (More)
Is this relevant?
2000
2000
High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
The high-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a sulfonamide… (More)
Is this relevant?